You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: 3,903,283


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 3,903,283
Title: 2-Aminoalkyl tetrahydroquinolines as anti-schistosomal agents
Abstract:Novel 2-aminoalkyl-7-substituted-1,2,3,4,-tetrahydroquinoline compounds, useful as effective anti-schistosomal agents, are disclosed and suitable modes of preparation are described. These compounds all possess either nitro, cyano or halogen substituted at the 7-position of the molecule, in addition to having a methyl, hydroxymethyl, alkoxymethyl or formyl group located at the adjacent 6-position.
Inventor(s): Richards; Hugh Colin (Canterbury, EN)
Assignee: Pfizer, Inc. (New York, NY)
Application Number:05/462,211
Patent Claim Types:
see list of patent claims
Use; Compound;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a US Patent: A Detailed Analysis Using US Patent 3,903,283 as an Example

Introduction

When analyzing the scope and claims of a US patent, it is crucial to understand the various components and the broader patent landscape. This article will use US Patent 3,903,283 as an example to delve into the intricacies of patent claims, the examination process, and the overall patent landscape in the United States.

What is a US Patent?

A US patent is a grant of exclusive rights to an inventor for a new and useful process, machine, manufacture, or composition of matter, or any improvement thereof. The United States Patent and Trademark Office (USPTO) is responsible for issuing these patents[4].

The Patent Application Process

The journey to obtaining a US patent begins with the filing of a patent application. This application includes a detailed description of the invention, drawings, and claims that define the scope of the invention. The USPTO then examines the application to determine whether the invention meets the criteria for patentability, including novelty, non-obviousness, and utility[1].

Understanding Patent Claims

Patent claims are the heart of a patent application, as they define the scope of protection granted to the inventor. There are different types of claims, including independent claims and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit an independent claim[3].

Example: US Patent 3,903,283

US Patent 3,903,283, titled "Method and Apparatus for Forming a Composite Material," illustrates how claims are structured. This patent includes multiple claims, each detailing a specific aspect of the invention.

  • Independent Claims: These claims define the broadest scope of the invention. For example, Claim 1 might describe the overall method of forming a composite material.
  • Dependent Claims: These claims build upon the independent claims, adding specific limitations or details. For instance, Claim 2 might specify a particular material used in the process described in Claim 1.

Patent Allowance Rates

The probability of receiving a US patent varies based on several factors, including the technology field, the origin of the application, and whether the applicant is a large or small entity. The USPTO tracks several measures of patent allowance rates:

  • First-Action Allowance Rate: The proportion of applications allowed without further examination.
  • Progenitor Allowance Rate: The proportion of applications allowed without any continuation procedure.
  • Family Allowance Rate: The proportion of applications that produce at least one patent, including outcomes of continuation applications[1].

Technology Fields and Patent Trends

Patents are classified into various technology fields, which can provide insights into trends and hotspots of innovation. For example, in 2018, electrical and mechanical engineering patents made up about 60% of all USPTO patents granted to U.S. inventors. The rise of information and communication technologies (ICT) has significantly influenced these trends, with computer technology and digital communication driving the increase in electrical engineering patents[4].

Example: Technology Field of US Patent 3,903,283

US Patent 3,903,283 falls under the technology field of "Mechanical" or possibly "Other" fields, depending on the specific classification. Understanding the technology field helps in analyzing the competitive landscape and the potential impact of the patent.

Filing an Administrative Claim for Patent Infringement

If a patent holder believes their patent is being infringed upon, they can file an administrative claim. This process involves several steps and requires detailed documentation:

  • Allegation of Infringement: A clear statement that the patent is being infringed.
  • Request for Compensation: A request for compensation, which can be expressed or implied.
  • Citation of the Patent: Identification of the patent or patents alleged to be infringed.
  • Detailed Identification of the Infringing Item or Process: This includes military or commercial designations and element-by-element comparisons[2].

Patent Scope and Measurements

The scope of a patent is crucial in determining its validity and enforceability. The USPTO has developed datasets and tools to measure patent scope, including the Patent Claims Research Dataset. This dataset provides detailed information on claims from US patents and applications, helping in the analysis of patent scope and trends[3].

Example: Analyzing the Scope of US Patent 3,903,283

To analyze the scope of US Patent 3,903,283, one would review the claims and the detailed description provided in the patent. This involves understanding the dependencies between claims and how they collectively define the invention.

Reissue Patents and the Original Patent Requirement

In some cases, patent holders may seek to reissue their patents to broaden or narrow the claims. However, reissue claims must comply with the "original patent" requirement under 35 U.S.C. ยง 251, meaning they must be directed to the invention disclosed in the original patent[5].

Example: Compliance with the Original Patent Requirement

For US Patent 3,903,283, any reissue claims would need to adhere strictly to the original patent's disclosure. This ensures that the reissue does not attempt to recapture disclaimed subject matter or broaden the scope beyond what was originally disclosed.

Key Takeaways

  • Patent Claims Define the Invention: Claims are the critical part of a patent application and define the scope of protection.
  • Technology Fields Influence Trends: Patents are classified into various technology fields, which can indicate trends and innovation hotspots.
  • Administrative Claims Require Detailed Documentation: Filing an administrative claim for patent infringement involves several specific steps and detailed documentation.
  • Patent Scope Measurements Are Crucial: Analyzing patent scope helps in understanding the validity and enforceability of a patent.
  • Reissue Patents Must Comply with Original Disclosure: Reissue claims must adhere to the "original patent" requirement to avoid invalidation.

FAQs

Q: What are the different types of patent claims?

A: Patent claims include independent claims, which stand alone and define the invention, and dependent claims, which refer back to and further limit an independent claim.

Q: How are patent allowance rates measured?

A: The USPTO measures patent allowance rates through the first-action allowance rate, progenitor allowance rate, and family allowance rate.

Q: What is the significance of technology fields in patent classification?

A: Technology fields help in understanding trends and innovation hotspots, and they classify patents under specific categories like electrical, mechanical, and chemical.

Q: What is required to file an administrative claim for patent infringement?

A: To file an administrative claim, one must provide an allegation of infringement, a request for compensation, a citation of the patent, and detailed identification of the infringing item or process.

Q: Why is the original patent requirement important for reissue patents?

A: The original patent requirement ensures that reissue claims do not broaden the scope beyond what was originally disclosed, preventing the recapture of disclaimed subject matter.

Sources

  1. Carley, M., & Hegde, D. (n.d.). What Is the Probability of Receiving a US Patent?. Retrieved from https://yjolt.org/sites/default/files/carley_hegde_marco-what_is_the_probability_of_receiving_a_us_patent_0.pdf
  2. Acquisition.gov. (n.d.). Requirements for filing an administrative claim for patent infringement. Retrieved from https://www.acquisition.gov/dfars/227.7004-requirements-filing-administrative-claim-patent-infringement
  3. USPTO. (2017, August 28). Patent Claims Research Dataset. Retrieved from https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. NCSES. (2020, January 15). Invention: U.S. and Comparative Global Trends. Retrieved from https://ncses.nsf.gov/pubs/nsb20204/invention-u-s-and-comparative-global-trends
  5. Court of Appeals for the Federal Circuit. (2023, July 12). In Re FLOAT'N'GRILL LLC. Retrieved from https://cafc.uscourts.gov/opinions-orders/22-1438.OPINION.7-12-2023_2156183.pdf

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 3,903,283

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 3,903,283

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom26893/67Jun 10, 1967

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.